Norges Bank
MRVI icon

Norges Bank’s Maravai LifeSciences MRVI Stock Holding History

Norges Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-299,380
Closed -$1.96M – 1943
2023
Q4 		$1.96M Hold
299,380
– – ﹤0.01% 1796
2023
Q3 		$2.99M Sell
299,380
-248,756
-45% -$2.73M ﹤0.01% 1775
2023
Q2 		$6.81M Sell
548,136
-355,624
-39% -$4.8M ﹤0.01% 1641
2023
Q1 		$12.7M Sell
903,760
-1,053,639
-54% -$15.1M ﹤0.01% 1484
2022
Q4 		$28M Buy
1,957,399
+579,860
+42% +$9.13M 0.01% 1115
2022
Q3 		$35.2M Buy
1,377,539
+349,715
+34% +$8.78M 0.01% 927
2022
Q2 		$29.2M Buy
1,027,824
+96,095
+10% +$3.04M 0.01% 1048
2022
Q1 		$32.9M Hold
931,729
– – 0.01% 1111
2021
Q4 		$39M Buy
931,729
+95,149
+11% +$3.85M 0.01% 1083
2021
Q3 		$41.1M Buy
836,580
+215,799
+35% +$10.5M 0.01% 1025
2021
Q2 		$25.9M Buy
+620,781
New +$24.1M 0.01% 1382
2021
Q1 		– Sell
-77,418
Closed -$2.17M – 2175
2020
Q4 		$2.17M Buy
+77,418
New +$2.16M ﹤0.01% 1945

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank's MRVI Position: Q1 2024 in Review

Norges Bank sold out of Maravai LifeSciences (MRVI) in Q1 2024, closing a stake of 299,380 shares — an estimated $1.96M sold.

Norges Bank first reported a position in MRVI in Q4 2020 and held it in 12 quarters. The position peaked at $41.1M in Q3 2021. 210 funds tracked by Wall St. Rank hold MRVI as of Q1 2024.

  • Norges Bank reported no remaining Maravai LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Norges Bank sold 299,380 Maravai LifeSciences shares in Q1 2024, an estimated $1.96M.
  • Norges Bank first reported a position in Maravai LifeSciences in Q4 2020 and held it in 12 quarters.
  • Norges Bank's Maravai LifeSciences position peaked at $41.1M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2024.

Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.